Literature DB >> 33357858

Fabrication of chondroitin sulfate calcium complex and its chondrocyte proliferation in vitro.

Qingshan Shen1, Chunhui Zhang2, Haizhen Mo3, Hongru Zhang1, Xiaojie Qin4, Juan Li4, Zhiqiang Zhang5, Aurore Richel6.   

Abstract

Chondroitin sulfate (CS)-calcium complex (CSCa) was fabricated, and the structural characteristics of CSCa and its proliferative bioactivity to the chondrocyte were investigated in vitro. Results suggested calcium ions could bind CS chains forming polysaccharide-metal complex, and the maximum calcium holding capacity of CSCa reached 4.23 %. Characterization of CSCa was performed by EDS, AFM, FTIR, UV, XRD and 1H-NMR. It was found that calcium ions were integrated with CS by binding the sulfate or carboxyl groups. The thermal properties analysis indicated CSCa had a good thermal stability by TGA and DSC. CSCa could interact the calcium-sensing receptor increasing the intracellular calcium ions and influence the cell cycle. The TGF-β1 secretion induced by CSCa could activate the TGF-β/Smads pathway and change the genes associated proliferation expression ultimately leading to the chondrocyte proliferation. This research probably has an important implication for understanding the effect of CSCa on bone care as food supplements.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone care; Calcium; Chondrocyte; Chondroitin sulfate; Proliferation

Mesh:

Substances:

Year:  2020        PMID: 33357858     DOI: 10.1016/j.carbpol.2020.117282

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

1.  Sulfation and Calcium Favor Compact Conformations of Chondroitin in Aqueous Solutions.

Authors:  Olgun Guvench; Elizabeth K Whitmore
Journal:  ACS Omega       Date:  2021-05-11

2.  Preparation and Characterization of Calcium-Incorporated Rosa roxburghii Tratt and Its Efficacy on Bone Mineral Density in Rats.

Authors:  Yanfang Yan; Zhongsheng Luo; Leilei He; Fuxiao Wei; Ming Gao; Xiaofang Cui; Juan Yang; Yichun Sun; Lilang Li; Lishou Yang; Tingfei Deng; Xiong Pan; Mei Peng; Yunfei Tan; Zhengbin An; Liangqun Li; Xiaosheng Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-20       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.